Induced protein degradation: an emerging drug discovery paradigm

Cited by (107)

Items 101–107 of 107

1. A critical evaluation of the approaches to targeted protein degradation for drug discovery
   Chopra, Rajesh, Sadok, Amine, Collins, Ian · 2019 · Drug Discovery Today: Technologies
2. Application of Novel Degraders Employing Autophagy for Expediting Medicinal Research
   Li, Xiang, Liu, Qian, Xie, Xin, Peng, Cheng, Pang, Qiwen, Liu, Bo, Han, Bo · 2023 · Journal of Medicinal Chemistry
3. Small-Molecule Degraders beyond PROTACs—Challenges and Opportunities
   Kastl, Johanna M., Davies, Gareth, Godsman, Eleanor, Holdgate, Geoffrey A. · 2021 · SLAS Discovery
4. 11-Oxygenated estrogens are a novel class of human estrogens but do not contribute to the circulating estrogen pool
   Barnard, Lise, Schiffer, Lina, Louw du-Toit, Renate, Tamblyn, Jennifer A, Chen, Shiuan, Africander, Donita, Arlt, Wiebke, Foster, Paul A, Storbeck, Karl-Heinz · 2021 · Endocrinology
5. Targeted protein modification as a paradigm shift in drug discovery
   Amirian, Roshanak, Azadi Badrbani, Mehdi, Izadi, Zhila, Samadian, Hadi, Bahrami, Gholamreza, Sarvari, Sajad, Abdolmaleki, Sara, Nabavi, Seyed Mohammad, Derakhshankhah, Hossein, Jaymand, Mehdi · 2023 · European Journal of Medicinal Chemistry
6. Resistance Mechanisms and Approach to Chronic Lymphocytic Leukemia after BTK Inhibitor Therapy
   Gruessner, Christine, Wiestner, Adrian, Sun, Clare · 2025 · Leukemia & Lymphoma
7. Destruction of DNA-binding proteins by programmable O’PROTAC: Oligonucleotide-based PROTAC
   Shao, Jingwei, Yan, Yuqian, Ding, Donglin, Wang, Dejie, He, Yundong, Pan, Yunqian, Yan, Wei, Kharbanda, Anupreet, Li, Hong-yu, Huang, Haojie · 2021